Seer Inc (SEER) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Seer Inc (SEER) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.57 Million) by net assets ($271.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Seer Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Seer Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Seer Inc for a breakdown of total debt and financial obligations.
Seer Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seer Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Waldencast Acquisition Corp
NASDAQ:WALD
|
-0.003x |
|
Calitech Co Ltd
TWO:6532
|
0.028x |
|
Celik Halat ve Tel Sanayi AS
IS:CELHA
|
-0.023x |
|
Diploma PLC
LSE:DPLM
|
0.174x |
|
Fino Payments Bank Limited
NSE:FINOPB
|
0.010x |
|
CVW CleanTech Inc
V:CVW
|
-0.037x |
|
ActRO Co. Ltd
KQ:290740
|
0.039x |
|
William Penn Bancorp Inc
NASDAQ:WMPN
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Seer Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Seer Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Seer Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $327.57 Million | $-46.11 Million | -0.141x | +5.41% |
| 2023-12-31 | $396.90 Million | $-59.06 Million | -0.149x | -9.44% |
| 2022-12-31 | $446.99 Million | $-60.78 Million | -0.136x | -47.55% |
| 2021-12-31 | $502.92 Million | $-46.35 Million | -0.092x | -90.97% |
| 2020-12-31 | $431.61 Million | $-20.83 Million | -0.048x | +67.63% |
| 2019-12-31 | $87.68 Million | $-13.07 Million | -0.149x | +3.91% |
| 2018-12-31 | $29.98 Million | $-4.65 Million | -0.155x | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab fo… Read more